Staccato Apomorphine Single and Multi Dose PK
Clinical trial NCT03822364 · COMPLETED
Trial details
- NCT number
- NCT03822364
- Sponsor
- Alexza Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2019-03-26
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.